Postantibiotic effects of gentamicin and netilmicin on Serratia marcescens: Effects on hydrophobicity and motility

Folia Microbiologica

Volumn 45, Issue , 2000, Pages 45-49

  Majtanova L' ^a   Majtan V ^a  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN; NETILMICIN;

ARTICLE; BACTERIUM ADHERENCE; DOSE RESPONSE; DRUG EFFECT; HUMAN; MOVEMENT (PHYSIOLOGY); PHYSIOLOGY; SERRATIA MARCESCENS;

ANTI-BACTERIAL AGENTS; BACTERIAL ADHESION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENTAMICINS; HUMANS; MOVEMENT; NETILMICIN; SERRATIA MARCESCENS;

EID: 0034565648     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02817449     Document Type: Article

References (30)

1. BARMADA S., KOLHEPP S., LEGGETT J., DWORKIN R., GILBERT D.: Correlation of tobramycin-induced inhibition of protein synthesis with postantibiotic effect in Escherichia coli. Antimicrob.Agents Chemother. 37, 2678-2683 (1993).
2. BEGG E.J., PEDDIE B.A., CHAMBERS S.T., BOSWELL D.R.: Comparison of gentamicin dosing regimens using an in-vitro model. J.Antimicrob.Chemother. 29, 427-433 (1992).
3. BLANCO J., ALONSO M.F., GONZALES E.A., BLANCO M., GARABAL J.J.: Virulence factors of bacteræsmic Escherichia coli with particular reference to production of cytotoxin necrotising factor (CNF) by P-fimbriate strains. J.Med.Microbiol. 31, 175-183 (1990).
4. CORIA-JIMENES R., ORTIZ-TORRES C.: Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin. Epidemiol.Infect. 112, 125-131 (1994).
5. COX C.E.: Aztreonam therapy for complicated urinary tract infections caused by multidrugresistant bacteria. Rev.Infect.Dis. 7 (Suppl. 1), 5767-5770 (1985).
6. CRAIG W.A., GUDMUNDSSON S.: The postantibiotic effect, pp. 515-536 in V. Lorian (Ed.): Antibiotics in Laboratory Medicine, 2nd ed. Williams and Wilkins, New York 1986.
7. CRAIG W.A., GUDMUNDSSON S.: The postantibiotic effect, pp. 403-431 in V. Lorian (Ed.): Antibiotics in Laboratory Medicine, 3rd ed. Williams and Wilkins, Baltimore 1991.
8. CRAVEN R.C, MONTIE T.C.: Motility and chemotaxis of three strains of Pseudomonas aeruginosa used of virulence studies. Can. J.Microbiol. 27, 458-460 (1981).
9. GILBERT D.N.: Once-daily aminoglycoside therapy. Antimicrob.Agents Chemother. 35, 399-405 (1991).
10. GOTTFREDSSON M., ERLENDSDÓTTIR H., KOLKA R., GUDMUNDSSON A., GUDMUNDSSON S.: Ultrastructural alterations of bacteria during the postantibiotic effect. Chemotherapy 39, 153-162 (1993).
11. GUAN L., BURNHAM J.C.: Postantibiotic effect of CI-960, enoxacin and ciprofloxacin on Escherichia coli: effect on morphology and hæmolysin activity. J.Antimicrob.Chemother. 29, 529-38 (1992).
12. HOGMAN C.F., FRITZ H., SANDBERG L.: Posttransfusion Serratia marcescens septicemia (editorial). Transfusion 33, 125-131 (1993).
13. HYBENOVÁ D., MAJTÁN V.: The influence of postantibiotic effect and postantibiotic effect of subinhibitory concentrations of some quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa. Pharmazie 52, 157-159 (1997).
14. ISAKSSON B., NILSSON L., MALLER R., SÖRÉN L.: Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method. J.Antimicrob.Chemother. 22, 23-33 (1988).
15. KADURUGAMUWA J.L., CLARKE A.J., BEVERIDGE T.J.: Surface action of gentamicin on Pseudomonas aeruginosa J.Bacteriol. 175, 5798-5805 (1993).
16. KARLOWSKY J.A., ZHANEL G.G., DAVIDSON R.J., HOBAN D.J.: Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro. J.Antimicrob.Chemother. 33, 937-947 (1994).
17. KÖRNER R.J., NICOL A., REEVES D.S., MACGOWAN A.P., HOWS J.: Ciprofloxacin resistant Serratia marcescens endocarditis as a complication of non Hodkin's lymphoma. J.Infect. 29, 73-76 (1994).
18. LACHICA R.V., ZINK D.L.: Plasmid-associated cell surface charge and hydrophobicity of Yersinia enterocolitica. Infect.Immun. 44, 540-543 (1984).
19. MAJTÁN V., MAJTÁNOVÁ L'.: Pharmacodynamic parameters of ofloxacin, tobramycin and ceftriaxone and their effect on the biological properties of Salmonelae. Arzneim.Forsch./Drug Res. 47, 1052-1055 (1997).
20. MAJTÁNOVÁ L'., MAJTÁN V.: Postantibiotic effects of imipenem and enoxacin against S. typhimurium and S. enteritidis and the influence on their surface hydrophobicity. Folia Microbiol. 43, 104-108 (1998a).
21. MAJTÁNOVÁ L'., MAJTÁN V.: Postantibiotic effect and postantibiotic sub-MIC effect of ciprofloxacin, pefloxacin, netilmicin and tobramycin on Enterobacter cloacae and their influence on hydrophobicity. Microbios 95, 155-164 (1998b).
22. MENG X., NIGHTINGALE C.A., SWEENEY K.R., QUINTILANI R.: Loss of bactericidal activities of quinolones during the postantibiotic effect induced by rifampicin. J.Antimicrob.Chemother. 40, 30-36 (1994).
23. ROSENBERG M., GUTNICK D., ROSENBERG E.: Adherence of bacteria to hydrocarbons: a simple method to measure cell surface hydrophobicity. FEMS Microbiol.Lett. 9, 29-33 (1980).
24. SAUTTER R.L., MATTMAN H.L., LEGASPI R.C.: Serratia marcescens meningitis associated with contaminated benzalkonium chloride solution. Infect.Control 5, 223-225 (1984).
25. TAWFIK A.F., RAMADAN M.A., SHIBL A.M.: Inhibition of motility and adherence of Proteus mirabilis to uroepithelial cells by subinhibitory concentrations of amikacin. Chemotherapy 43, 424-429 (1997).
26. VANLOOSDRECHT M.C.M., LYKLEMA J., NORDE W., SCHRAA G., ZEHNDER A.J.B.: Electrophoretic mobility and hydrophobicity as a measure to predict the initial steps of bacterial adhesion. Appl.Environ.Microbiol. 58, 1898-1901 (1987).
27. VOGELMAN B., GUDMUNDSSON S., TURNIDGE J., LEGETT J., CRAIG W.A.: In vivo postantibiotic effect in a thigh infection in neutropenic mice. J.Infect.Dis. 157, 287-298 (1988).
28. ZHANEL G.G., KARLOWSKY J.A., HOBAN D.J., DAVIDSON R.J.: Antimicrobial activity of subinhibitory concentrations of aminoglycosides against Pseudomonas aeruginosa as determined by the killing curve method and the postantibiotic effect. Chemotherapy 37, 114-121 (1991).
29. ZHANEL G.G., ARIANO R.E.: Once daily aminoglycoside dosing: maintained efficacy with reduced nephrotoxicity. Renal Failure 14, 1-9 (1992).
30. ZHANEL G.G., CRAMPTON J., KIM S., NICOLLE L.E., DAVIDSON R.J., HOBAN D.J.: Antimicrobial activity of subinhibitory concentrations of ciprofloxacin against Pseudomonas aeruginosa as determined by the killing curve method and the postantibiotic effect. Chemotherapy 38, 388-394 (1992).